Medical Device News Magazine

Healthtech Leader Eon Announces 1MM Patients Impacted by Their Incidental Findings and Screening Software

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Eon, a leading provider of incidental findings and screening patient management software, announced today that it has surpassed 1MM patients impacted by their proprietary AI software and services.

Eon provides a cloud-based patient management platform that enables hospitals and health systems to capture and longitudinally track patients at risk for future catastrophic diagnoses, creating a stage shift in the early detection of cancer and possible prevention of ruptured aneurysms.

Dr. Aki Al-Zubaidi, Eon Founder & CEO, is an Interventional Pulmonologist who founded Eon in 2013 to solve a clinical problem he experienced firsthand – lung cancer was most often diagnosed at a late stage where the likelihood of survival for those diagnosed was low. He knew that by tracking patients with lung nodules found early on regular radiology exams, he could diagnose lung cancer at earlier stages. He also knew the solution Eon had created was scalable and has since been deployed for multiple diseases including Pancreas, Liver, Thyroid, AAA, and Breast, with a considerable number of disease solutions in development. Eon continues to lead with patient care at the forefront of its mission while providing solutions that create significant service line growth and impactful downstream revenue for its customers.

“I am incredibly proud that we have achieved a significant milestone by positively impacting over 1,000,000 individuals,” said Dr. Al-Zubaidi. “This accomplishment is a testament to the dedication, tireless efforts, and collective action of our entire team, as well as our unwavering commitment to making patients healthy and healthcare affordable. We remain committed to the pursuit of further advancements as we continue to push boundaries, invest in innovative solutions, and strive for excellence in delivering life-saving solutions that make financial sense. Our ultimate goal is to touch the lives of millions more, creating a lasting impact on global healthcare outcomes.”

The Eon Patient Management (EPM) platform leverages computational linguistics, an advanced form of artificial intelligence, along with robust data science models to accurately capture incidental findings in healthcare records. EPM triages patients that need a follow-up exam, automates communication with patients and providers, and flags the care team when exams are ordered, completed, missed, or overdue. Eon also offers a tech-enabled care navigation service that helps hospital care teams offload administrative tasks and reach more patients. “Because of the early intervention that many of these people have received, their opportunity to live a full, healthy life has been positively impacted. These million patients represent our neighbors, brothers, sisters, parents and friends,” said Dr. Scott Skibo, Chief Medical Officer at Eon Health.

Today, Eon is used by over 45 health systems and 500+ facilities across the United States. Notable partner health systems include UCHealth, LifePoint Health, HCA Healthcare, Ascension, Hospital Sisters Health System, Cleveland Clinic, and Geisenger.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”